← Current compounder rows

Current NDC auxiliary source row compounder:3310

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
79559-6187
Product Ndc
79559-6187
Product Ndc Digits
795596187
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
S-TT087.5
Proprietary Name Suffix
[empty]
Nonproprietary Name
S-TT087.5
Dosage Form Name
PELLET, IMPLANTABLE
Route Name
SUBCUTANEOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
F. H. Investments. Inc. DBA Asteria Health
Establishment Name
F. H. Investments. Inc. DBA Asteria Health
Establishment Fei
[empty]
Substance Name
TESTOSTERONE; TRIAMCINOLONE ACETONIDE
Active Ingredients Info
87.5 mg/87.5175 mg; .0175 mg/87.5175 mg
History Active Ingredients Raw
TESTOSTERONE; TRIAMCINOLONE ACETONIDE
History Active Ingredients Info Raw
87.5 mg/87.5175 mg; .0175 mg/87.5175 mg
History Dosage Raw
PELLET, IMPLANTABLE
Dea Schedule
CIII
Package Ndc Raw
79559-6187-1
Package Ndc
79559-6187-1
Package Ndc Digits
7955961871
Package Ndc11
79559618701
Package Description
87.5175 mg in 1 VIAL, PLASTIC (79559-6187-1)
Reporting Period Raw
2026-1
Reporting Period
2026-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3310
Source Row Number
3310
Source Row Hash
53c608fede04572754693340760499b2d4652005e8e88c04d583f7bae9ea64e3
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "SUBCUTANEOUS",
    "PRODUCTNDC": "79559-6187",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "F. H. Investments. Inc. DBA Asteria Health",
    "SUBSTANCENAME": "TESTOSTERONE; TRIAMCINOLONE ACETONIDE",
    "DOSAGEFORMNAME": "PELLET, IMPLANTABLE",
    "NDCPACKAGECODE": "79559-6187-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "S-TT087.5",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "S-TT087.5",
    "PACKAGEDESCRIPTION": "87.5175 mg in 1 VIAL, PLASTIC (79559-6187-1) ",
    "ACTIVEINGREDIENTSINFO": "87.5 mg/87.5175 mg; .0175 mg/87.5175 mg",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3310
Source Row Number
3310
Status Scope
package
Lookup Ndc
79559-6187-1
Lookup Ndc Digits
7955961871
Product Ndc
79559-6187
Product Ndc Digits
795596187
Package Ndc
79559-6187-1
Package Ndc Digits
7955961871
Package Ndc11
79559618701
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2026-1
Reporting Period
2026-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
53c608fede04572754693340760499b2d4652005e8e88c04d583f7bae9ea64e3
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45